相关实验视频
Updated: Jul 1, 2025

06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
708
克鲁茨菲尔特-雅各布病和其他病
Inga Zerr1, Anna Ladogana2, Simon Mead3
1National Reference Center for CJD Surveillance, Department of Neurology, University Medical Center, Georg August University, Göttingen, Germany. ingazerr@med.uni-goettingen.de.
Nature reviews. Disease primers
|February 29, 2024
概括
以异常的蛋白误折叠为特征的子疾病,具有独特的诊断和治疗挑战. 最近的进展为改善这些罕见的神经退行性疾病的诊断和未来治疗提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 传染性疾病 传染性疾病
背景情况:
- 子疾病是致命的神经退行性疾病,其特点是海绵状退化和异常的子蛋白 (PrPSc) 积累.
- 关键特征包括长时间的潜伏期,快速的临床衰退,耐降解性和缺乏核酸参与.
- 这些疾病以零星的,遗传的 (PRNP突变),有毒的和动物感染的形式表现,影响人类和动物的健康.
研究的目的:
- 审查当前对病特征,病原和诊断方法的理解.
- 突出诊断工具和新兴治疗策略的最新进展.
- 强调病研究对于更广泛地理解神经退行性疾病的重要性.
主要方法:
- 对病的临床和病理特征的审查.
- 诊断方式的分析,包括神经成像,脑脊液测试和蛋白聚合测试.
- 检查当前和新兴的治疗策略和临床试验.
主要成果:
- 性疾病表现出明显的神经病理特征和传播途径.
- 诊断能力有了显著的进步,聚合试验显示了基于生物流体的检测的前景.
- 在长期有限的治疗选择之后,新的治疗途径正在出现.
结论:
- 尽管很罕见,但子疾病是神经退行性疾病的关键模型.
- 对蛋白错折叠机制的持续研究对于开发有效的诊断和治疗至关重要.
- 病管理的前景包括改善诊断准确性和新的治疗干预措施.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
631
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
631
Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K

